A single consent for all the treatments in the practice does not hold up, because the law requires you to inform the patient about the risks and alternatives of the treatment you are proposing, and a filler, a toxin and a laser do not carry the same risks. Informed consent is written treatment by treatment: name, area, product or technique, what can go wrong in that case, what happens if nothing is done.
This article is for the doctor who currently uses a single form, or a form taken from another practice. It does not give you a text to copy: the risks and the percentages in a consent form are for you to decide, using the guidelines of your scientific society and the leaflet of the product you use. It tells you what the sources require you to put in the information, and where it changes from one treatment to another.
Why the single form is weak
The law speaks of «treatment» in the singular and of information «indicated» for the case. The Code of Medical Ethics (opens in a new tab) at Article 33 requires information that is understandable and exhaustive on the therapy, the alternatives, the «foreseeable risks and complications» and the behaviour to follow afterwards. Article 76 bis, the one on aesthetic medicine, adds that the information preceding written consent must not foster illusory expectations and must indicate alternatives of equal efficacy.
A text valid for everything can indicate neither the foreseeable risks of a toxin nor those of a laser. If one day someone asks you what you told that patient about that treatment, a generic form answers very little. The pages on the site about generic consent gather the rules and court decisions on this point.
Injectables: product, area, known effects
For a filler based on hyaluronic acid or another material, the items that change compared with other treatments are three.
The product and the site. European Regulation 2022/2346 (opens in a new tab), for the products falling under Annex IV (facial and skin fillers), requires the manufacturer to include a written annex for the patient in the instructions. It must contain the residual risks, the undesirable effects, the contraindications and when to contact a healthcare professional. It also requires a section where the practitioner can record the site, number and volume of the injections, and instructs the user to give the patient a copy before the treatment. This is an obligation on the manufacturer towards the user of the product, and for you it becomes something concrete: handing over that sheet is part of what you can show you did.
The reactions that come later. A systematic review on lip fillers (2024) distinguishes early reactions, localised at the injection point and often resolving on their own, from delayed ones, which are persistent and may require surgical intervention. The authors write that it is important to inform the patient of the possibility of reactions even months or years later and of the need for follow-up after the initial result. For a consent form this means one extra line, specific to fillers: you are not only talking about swelling and bruising in the following week.
What was injected. The product, the batch and the expiry date belong in the session record, and the consent form refers to them. If the product changes, the consent form naming the other one no longer applies to this one.
For botulinum toxin, the sources in the brain indicate other items. A review on the toxin lists as local effects the pain of the injection, oedema, erythema, bruising (more likely if the patient takes aspirin, vitamin E or anti-inflammatories) and headache, and as an effect to be aware of the spread to nearby muscles, for example eyelid ptosis, which in the text usually lasts from two to six weeks. The label approved by the American FDA for BOTOX carries a prominent warning about the distant spread of the toxin's effect, with symptoms that may appear from hours to weeks after the injection, and warns that the units of one product are not interchangeable with those of another. That label is American and concerns the therapeutic indications of the product: for the consent form you must start from the summary of product characteristics of the product you use, authorised in Italy.
Energy-based techniques: phototype, parameters, adverse effects
For lasers, pulsed light and other energy devices, the type of risk changes. A 2026 article on the complications of lasers and energy devices indicates the Fitzpatrick phototype as the most important patient-related factor: those with darker skin have a higher risk of pigmentation changes, because melanin absorbs part of the energy. It also mentions sun exposure, before and after, and recommends a full consultation that includes sun protection in the four weeks before and after. Finally, it flags an effect the patient does not expect: a laser used for capillaries can also reduce hair in the same area, and the patient must be warned beforehand.
Regulation 2022/2346 has an annex for these devices, Annex VI, which applies to lasers and intense pulsed light. For professional-use devices it requires two things that touch on consent: giving the patient an information sheet before the treatment, and ensuring that the person using the device can assess the patient's suitability and give adequate advice on the risks and possible results, taking into account their clinical history and the medicines they take.
In practice, a consent form for an energy-based technique contains things a consent form for an injectable does not have: phototype, recent sun exposure, type of device and parameters if you declare them, aftercare following the session. A consent form for a peel is built on the product leaflet and the guidelines of your scientific society.
What is repeated at every session and what covers a course
The law says the treatment cannot be «started or continued» without consent. It does not say how many sessions one signature covers, and it does not set an expiry date. You set the practical rule, and it is worth writing it down.
- It covers the whole course when nothing changes: same technique, same product, same area, risks already explained. A series of sessions with the same technique on the same area can rely on a single consent form, if the text refers to a course and says so.
- It is redone when something substantial changes: another product, another area, another technique, another device, a new condition or a new therapy for the patient.
- It is repeated verbally at every session, and noted down: how the patient is, what has changed since last time, whether they want to ask questions. The signed consent form does not replace this conversation, and under the law (opens in a new tab) communication time is care time.
The Code says, at Article 35, that obtaining consent is an act of specific and exclusive medical competence, which cannot be delegated.
How consent is linked to the session in the record
A consent form that is not linked to a session is just a sheet of paper. In Fibonacci, consent is generated from a template and carries the patient's, the practice's and the doctor's data; the product, the area and the batch are left for you to fill in. The session is recorded with its product and its batch, and the signed consent form is a prerequisite: if it is missing, the session is still saved and remains flagged as having no consent. What was done is not hidden.
If the technique changes, a new consent form is prepared: the previous one is not modified and stays in the patient's history. Allergies, current therapies and comorbidities are declared in the data step, even as «none».
A checklist before asking for a signature:
- The consent form names today's treatment, not «the practice's treatments»
- The product or device, and the area, are today's
- Risks of the treatment, including those appearing days or months later
- Alternatives, including doing nothing
- For an injectable: the manufacturer's sheet has been handed over, and the handover is noted
- For an energy-based technique: phototype, sun exposure and aftercare following the session
- Allergies, therapies and conditions declared by the patient
- The patient's questions, and what you answered
Why you should not copy other practices' forms
A form copied from another practice describes the risks of another product, and on the day it matters it says things you never said. Fibonacci provides proprietary templates: they are drafts, their clinical content has not been validated by a healthcare lawyer or by a doctor in the specialty, so they must be reviewed and adopted by you before use. Alternatively you upload your scientific society's form or one of your own, and it stays only in your practice. For a treatment that is not in the catalogue, that is the normal route.
What you need, in the end, is little: a consent form that says which treatment, with which risks, and that you have reread word by word.




